Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History → LEAKED: Jeff Bezos' $330 Million Gamble (From Behind the Markets) (Ad) Free CMMB Stock Alerts $1.07 +0.01 (+0.94%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Chemomab Therapeutics Stock Price Performance5 Day Performance+22.98%1 Month Performance+47.49%3 Month Performance+62.11%6 Month Performance+101.87%Year-To-Date Performance+109.78%1 Year Performance-33.13% Receive CMMB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsLEAKED: Jeff Bezos' $330 Million GambleDid you know that 3 simple words are disrupting a $62.7 billion market? "Blood Brain Barrier" Seems innocent enough.Here's how you could invest alongside them >>> CMMB Stock Chart for Saturday, June, 1, 2024 CMMB Chart by TradingView Chemomab Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.06$1.07+0.94%$1.07$0.99204,436 shs$11.82 million05/30/2024$0.95$1.06+11.57%$1.08$0.89219,594 shs$11.71 million05/29/2024$0.91$0.95+4.54%$0.97$0.87155,299 shs$10.50 million05/28/2024$0.87$0.91+4.46%$0.95$0.85189,062 shs$10.04 million05/27/2024$0.87$0.87$0.88$0.8412,700 shs$9.61 million05/24/2024$0.84$0.87+3.69%$0.88$0.8412,729 shs$9.61 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.84$0.84-0.12%$0.88$0.8153,890 shs$9.27 million05/22/2024$0.82$0.84+2.44%$0.85$0.8219,363 shs$9.28 million05/21/2024$0.86$0.82-4.65%$0.88$0.8269,972 shs$9.06 million05/20/2024$0.84$0.86+2.26%$0.86$0.8314,995 shs$9.50 million05/17/2024$0.87$0.84-3.33%$0.88$0.8353,810 shs$9.29 million05/16/2024$0.87$0.87-0.23%$0.88$0.8242,980 shs$9.61 million05/15/2024$0.88$0.87-0.91%$0.88$0.8255,086 shs$9.64 million05/14/2024$0.81$0.88+8.11%$0.88$0.81100,414 shs$9.72 million05/13/2024$0.84$0.81-2.98%$0.88$0.8147,004 shs$9.00 million05/10/2024$0.81$0.84+3.58%$0.85$0.7666,540 shs$9.27 million05/09/2024$0.73$0.81+11.72%$0.85$0.69124,839 shs$8.95 million05/08/2024$0.89$0.73-18.42%$0.90$0.60423,449 shs$8.01 million05/07/2024$0.85$0.89+4.21%$0.97$0.76401,034 shs$9.82 million05/06/2024$0.74$0.85+15.24%$0.91$0.801.26 million shs$9.42 million05/03/2024$0.74$0.74+0.65%$0.74$0.7013,292 shs$8.18 million05/02/2024$0.73$0.74+1.35%$0.74$0.6712,160 shs$8.12 million05/01/2024$0.70$0.73+3.63%$0.73$0.6660,165 shs$8.02 million04/30/2024$0.68$0.70+2.94%$0.72$0.6613,802 shs$7.74 million04/29/2024$0.64$0.68+6.27%$0.69$0.6219,959 shs$7.51 million04/26/2024$0.66$0.64-2.90%$0.65$0.6223,560 shs$7.07 million04/25/2024$0.67$0.66-1.64%$0.68$0.6311,539 shs$7.28 million04/24/2024$0.67$0.67$0.68$0.653,373 shs$7.40 million04/23/2024$0.66$0.67+1.53%$0.68$0.647,157 shs$7.40 million04/22/2024$0.68$0.66-2.96%$0.67$0.629,520 shs$7.29 million04/19/2024$0.70$0.68-2.86%$0.74$0.6615,392 shs$7.51 million04/18/2024$0.59$0.70+18.64%$0.70$0.6229,623 shs$7.74 million04/17/2024$0.66$0.59-10.70%$0.69$0.5847,936 shs$6.52 million04/16/2024$0.73$0.66-9.49%$0.74$0.6637,664 shs$7.30 million04/15/2024$0.77$0.73-5.17%$0.77$0.7250,209 shs$8.07 million04/12/2024$0.76$0.77+1.29%$0.79$0.7511,602 shs$8.51 million04/11/2024$0.79$0.76-3.80%$0.79$0.7637,690 shs$8.40 million04/10/2024$0.79$0.79$0.80$0.7813,545 shs$8.73 million04/09/2024$0.79$0.79-0.08%$0.80$0.7815,638 shs$8.73 million04/08/2024$0.80$0.79-1.18%$0.80$0.7872,926 shs$8.74 millionThe only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here04/05/2024$0.79$0.80+1.28%$0.80$0.7735,680 shs$8.84 million04/04/2024$0.81$0.79-2.12%$0.80$0.7643,417 shs$8.73 million04/03/2024$0.77$0.81+5.49%$0.81$0.7555,417 shs$8.92 million04/02/2024$0.77$0.77$0.77$0.7416,400 shs$8.45 million04/01/2024$0.78$0.77-1.80%$0.79$0.7633,958 shs$8.45 million03/29/2024$0.78$0.78$0.78$0.7528,961 shs$8.61 million03/28/2024$0.77$0.78+1.17%$0.78$0.7528,961 shs$8.61 million03/27/2024$0.75$0.77+2.80%$0.78$0.7048,121 shs$8.51 million03/26/2024$0.73$0.75+3.03%$0.77$0.7044,367 shs$8.28 million03/25/2024$0.77$0.73-5.60%$0.80$0.70294,863 shs$8.03 million03/22/2024$0.79$0.77-2.40%$0.79$0.7625,006 shs$8.51 million03/21/2024$0.79$0.79-0.01%$0.82$0.7634,183 shs$8.72 million03/20/2024$0.77$0.79+2.45%$0.81$0.7579,554 shs$8.72 million03/19/2024$0.80$0.77-3.19%$0.80$0.76120,379 shs$8.51 million03/18/2024$0.80$0.80-0.48%$0.81$0.7728,062 shs$8.79 million03/15/2024$0.83$0.80-3.58%$0.83$0.7812,293 shs$8.83 million03/14/2024$0.82$0.83+0.61%$0.83$0.7761,375 shs$9.16 million03/13/2024$0.86$0.82-4.19%$0.88$0.81132,529 shs$9.11 million03/12/2024$0.82$0.86+4.26%$0.88$0.81202,130 shs$9.50 million03/11/2024$0.78$0.82+6.44%$0.83$0.77211,271 shs$9.12 million03/08/2024$0.80$0.78-3.13%$0.80$0.7597,778 shs$8.56 million03/07/2024$0.71$0.80+12.63%$0.82$0.71299,369 shs$8.84 million03/06/2024$0.65$0.71+9.78%$0.73$0.64310,081 shs$7.85 million03/05/2024$0.66$0.65-1.30%$0.65$0.6234,173 shs$7.15 million03/04/2024$0.66$0.66-0.68%$0.67$0.6241,599 shs$7.24 million03/01/2024$0.69$0.66-3.65%$0.67$0.6361,773 shs$7.29 million02/29/2024$0.68$0.69+1.18%$0.69$0.6537,317 shs$7.57 million Related Companies: ATHE Stock Chart ADXN Stock Chart UPC Stock Chart NCNA Stock Chart MTEM Stock Chart CANF Stock Chart VCNX Stock Chart GRAY Stock Chart RNAZ Stock Chart KTRA Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss Ratings“This will be one of the biggest revolutions ever.” - NVIDIA CEOBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.